Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alsoKnownAs |
gptkb:vadadustat
|
| gptkbp:ATCCode |
B03XA10
|
| gptkbp:CASNumber |
1000025-07-9
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:developedBy |
gptkb:Akebia_Therapeutics
|
| gptkbp:hasMolecularFormula |
C14H16N4O2
|
| https://www.w3.org/2000/01/rdf-schema#label |
AKB-6548
|
| gptkbp:intendedUse |
treatment of anemia
|
| gptkbp:mechanismOfAction |
HIF prolyl-hydroxylase inhibitor
|
| gptkbp:PubChem_CID |
25154816
CHEMBL2103887 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational drug
|
| gptkbp:target |
hypoxia-inducible factor (HIF) pathway
|
| gptkbp:UNII |
6K7D1M2N1B
|
| gptkbp:bfsParent |
gptkb:vadadustat
|
| gptkbp:bfsLayer |
8
|